Shares of North Carolina clinical research organization PPD (NYSE:PPDI) climbed on reports that the company is for sale. PPD shares are trading at $32.35 on Monday morning, up more than 16 percent over Friday’s close. Shares later leveled off at $30.92 cents per share. The Wall Street Journal cited unnamed “people familiar with the matter” […]
PPD (NYSE:PPDI) is expanding its consulting services into four new areas, signaling the kinds of services that the Wilmington, North Carolina clinical research organization believes will be growth opportunities. The CRO’s consulting arm, PPD Consulting, has added biosimilars, adaptive trial design, China regulatory strategy and cardiovascular outcome studies as four new practice areas for the […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A North Carolina CRO stands atop the rankings of a major industry survey and it’s not Quintiles. PPD (NYSE:PPDI), based in Wilmington, North Carolina, is the top-rated global clinical research organization in the 2011 CenterWatch Global Investigative Site Survey. The results are based on survey responses from clinical research site professionals in more than 70 […]
PPD‘s net income soared to $37.3 million in the first quarter, more than double the profits the clinical research organization reported a year ago, as the Wilmington, North Carolina-based company continued to report strong growth providing clinical trial services to pharmaceutical companies. First-quarter net revenue for PPD (NASDAQ:PPDI) was $383.2 million, a more than 10 […]